Health Technology/clinical-trials

EMR-Integrated Platform Nest Targets the Surveillance Gap in Young Adults Carrying Hereditary Cancer Variants — Trial Details for Clinicians

247 Health News Editorial

·

18 July 2026

·

5 min read

·clinical-trials

A US-based clinical trial is evaluating Nest, an EMR-integrated platform designed to improve cancer surveillance adherence and reduce psychological distress in young adults carrying pathogenic hereditary cancer variants. Conducted at Dana-Farber Cancer Institute, the study targets a critical gap between genetic diagnosis and long-term clinical follow-through. Australian familial cancer clinicians should monitor outcomes as the model has direct relevance to local practice.

Originally reported by ClinicalTrials.gov

References

  1. 1.Nest Genomics. (2024). Enhancing information management for young adults after genetic cancer risk testing (NCT06654466). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06654466
  2. 2.Childers, C. P., Childers, K. K., Maggard-Gibbons, M., & Macinko, J. (2017). National estimates of genetic testing in women with a history of breast or ovarian cancer. Journal of Clinical Oncology, 35(34), 3800–3806. https://doi.org/10.1200/JCO.2017.73.6314
  3. 3.Oliveri, S., Cincidda, C., Peiró, G., Renzi, C., & Pravettoni, G. (2021). What does distress mean for cancer patients? A qualitative study on the experience of distress and its relationship with quality of life. Frontiers in Psychology, 12, 644126. https://doi.org/10.3389/fpsyg.2021.644126
  4. 4.Bonadies, D. C., Moyer, A., Matloff, E. T., & Brierley, K. L. (2011). Implications of incomplete adherence to cancer surveillance recommendations in BRCA1/2 mutation carriers. Familial Cancer, 10(4), 745–751. https://doi.org/10.1007/s10689-011-9437-1
  5. 5.Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015). American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 33(31), 3660–3667. https://doi.org/10.1200/JCO.2015.63.0996
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service